NASDAQ interview $EDXC Monday, record Q2 numbers d
Post# of 98059
(Total Views: 158)
Posted On: 04/02/2020 3:16:34 PM
NASDAQ interview $EDXC Monday, record Q2 numbers discussed:
Record Q2 numbers coming
Nasdaq interview next week
Equine CBD
Completes acquisition of Kush Inc
https://finance.yahoo.com/quote/edxc
https://finance.yahoo.com/news/cbd-unlimited-...10473.html
CBD Unlimited Updates Stakeholders in Interview Via Remote Location at Nasdaq MarketSite
GlobeNewswire GlobeNewswireMarch 31, 2020
Company’s CEO, Todd Davis, discusses second quarter activity
CAVE CREEK, AZ, March 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, announced today that the Company was interviewed by reporter Jane King to discuss key activities and updates for its fiscal second quarter.
The update interview will be available on April 6, 2020.
CBD Unlimited’s CEO and Chairman, Todd Davis, had an interview on Friday, March 20, as Nasdaq and Wall Street were going into Coronavirus 19 lockdown mode.
Mr. Davis commented that “updating shareholders is critical in these times of uncertainty. CBD Unlimited has set new records in the quarter ending March 31, in spite of a challenging environment, and has accelerated its growth initiatives going forward for the second half of the fiscal year and into 2021.”
About CBD Unlimited, Inc.
CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.
In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.
Website: www.cbdunlimited.com
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
Contact:
For further investor and media information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
Todd@cbdunlimited.com
480-595-6900
Record Q2 numbers coming
Nasdaq interview next week
Equine CBD
Completes acquisition of Kush Inc
https://finance.yahoo.com/quote/edxc
https://finance.yahoo.com/news/cbd-unlimited-...10473.html
CBD Unlimited Updates Stakeholders in Interview Via Remote Location at Nasdaq MarketSite
GlobeNewswire GlobeNewswireMarch 31, 2020
Company’s CEO, Todd Davis, discusses second quarter activity
CAVE CREEK, AZ, March 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, announced today that the Company was interviewed by reporter Jane King to discuss key activities and updates for its fiscal second quarter.
The update interview will be available on April 6, 2020.
CBD Unlimited’s CEO and Chairman, Todd Davis, had an interview on Friday, March 20, as Nasdaq and Wall Street were going into Coronavirus 19 lockdown mode.
Mr. Davis commented that “updating shareholders is critical in these times of uncertainty. CBD Unlimited has set new records in the quarter ending March 31, in spite of a challenging environment, and has accelerated its growth initiatives going forward for the second half of the fiscal year and into 2021.”
About CBD Unlimited, Inc.
CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.
In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.
Website: www.cbdunlimited.com
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
Contact:
For further investor and media information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
Todd@cbdunlimited.com
480-595-6900
(0)
(0)Scroll down for more posts ▼